Adaptimmune Therapeutics Plc - ADR Live Share Price Today, Share Analysis and Chart

Name: Adaptimmune Therapeutics Plc - ADR: Is Infosys Ltd. worth buying?
Item: Adaptimmune Therapeutics Plc - ADR
Rating: 1.16066675
Author: Trendlyne DVM scores

about

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

0.28 0.03 (12.00%)

81.08% Fall from 52W High

906.2K

XNAS Volume

XNAS 09 Jul, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

15.7 / 100

Technically Bearish

30.8 / 100

1Yr Price target upside is 418%

8 analysts

Adaptimmune Therapeutics P... Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Adaptimmune Therapeutics Plc - ADR Live Share Price Today, Share Analysis and Chart

Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer target...

81.08% Fall from 52W High

SWOT Analysis

Adaptimmune Therapeutics P... Live Price Chart